These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 26463597)

  • 1. Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.
    Li L; Wang X; Chen W; Qi H; Jiang DS; Huang L; Huang F; Wang L; Li H; Chen X
    Basic Res Cardiol; 2015 Nov; 110(6):56. PubMed ID: 26463597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction.
    Bao MW; Cai Z; Zhang XJ; Li L; Liu X; Wan N; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
    Basic Res Cardiol; 2015 May; 110(3):25. PubMed ID: 25840773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis.
    Wan N; Liu X; Zhang XJ; Zhao Y; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
    Br J Pharmacol; 2015 Jul; 172(13):3383-96. PubMed ID: 25765712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.
    Bao MW; Zhang XJ; Li L; Cai Z; Liu X; Wan N; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
    J Pathol; 2015 Jul; 236(3):360-72. PubMed ID: 25726944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulator of G-protein signalling 5 deficiency impairs ventricular remodelling after myocardial infarction by promoting NF-κB and MAPK signalling in mice.
    Ding HS; Huang Y; Chen Z; Tang YH; Wang DD; Fan D; Huang CX
    Biochem Biophys Res Commun; 2018 May; 499(2):143-149. PubMed ID: 29534968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCP-1-induced protein attenuates post-infarct cardiac remodeling and dysfunction through mitigating NF-κB activation and suppressing inflammation-associated microRNA expression.
    Niu J; Jin Z; Kim H; Kolattukudy PE
    Basic Res Cardiol; 2015 May; 110(3):26. PubMed ID: 25840774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of Capn4 gene inhibits nuclear factor-κB (NF-κB) protein signaling/inflammation and reduces remodeling after myocardial infarction.
    Ma J; Wei M; Wang Q; Li J; Wang H; Liu W; Lacefield JC; Greer PA; Karmazyn M; Fan GC; Peng T
    J Biol Chem; 2012 Aug; 287(33):27480-9. PubMed ID: 22753411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of Pellino1 improves post-infarct cardiac dysfunction and attenuates left ventricular remodelling in mice.
    Wu W; Hu Y; Li J; Zhu W; Ha T; Que L; Liu L; Zhu Q; Chen Q; Xu Y; Li C; Li Y
    Cardiovasc Res; 2014 Apr; 102(1):46-55. PubMed ID: 24442869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction.
    Luedde M; Lutz M; Carter N; Sosna J; Jacoby C; Vucur M; Gautheron J; Roderburg C; Borg N; Reisinger F; Hippe HJ; Linkermann A; Wolf MJ; Rose-John S; Lüllmann-Rauch R; Adam D; Flögel U; Heikenwalder M; Luedde T; Frey N
    Cardiovasc Res; 2014 Jul; 103(2):206-16. PubMed ID: 24920296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
    Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
    Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARD3 Promotes Cerebral Ischemia-Reperfusion Injury Via Activation of TAK1.
    Wu X; Lin L; Qin JJ; Wang L; Wang H; Zou Y; Zhu X; Hong Y; Zhang Y; Liu Y; Xin C; Xu S; Ye S; Zhang J; Xiong Z; Zhu L; Li H; Chen J; She ZG
    J Am Heart Assoc; 2020 May; 9(9):e014920. PubMed ID: 32349637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-κB signaling pathway.
    He Q; Zhou W; Xiong C; Tan G; Chen M
    Mol Med Rep; 2015 Jan; 11(1):374-8. PubMed ID: 25323011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc Finger Protein ZBTB20 protects against cardiac remodelling post-myocardial infarction via ROS-TNFα/ASK1/JNK pathway regulation.
    Li F; Yang Y; Xue C; Tan M; Xu L; Gao J; Xu L; Zong J; Qian W
    J Cell Mol Med; 2020 Nov; 24(22):13383-13396. PubMed ID: 33063955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
    Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
    J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
    Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
    Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
    Reboll MR; Korf-Klingebiel M; Klede S; Polten F; Brinkmann E; Reimann I; Schönfeld HJ; Bobadilla M; Faix J; Kensah G; Gruh I; Klintschar M; Gaestel M; Niessen HW; Pich A; Bauersachs J; Gogos JA; Wang Y; Wollert KC
    Circulation; 2017 Nov; 136(19):1809-1823. PubMed ID: 28931551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-specific overexpression of oestrogen receptor β improves survival and cardiac function after myocardial infarction in female and male mice.
    Schuster I; Mahmoodzadeh S; Dworatzek E; Jaisser F; Messaoudi S; Morano I; Regitz-Zagrosek V
    Clin Sci (Lond); 2016 Mar; 130(5):365-76. PubMed ID: 26608078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.